RxDoctor Payments Data

Benjamin Martin, MD

Colon & Rectal Surgery · Westwood, KSNPI 1881855104

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (36.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 74.3% of it on its own, with 11 other manufacturers making up the rest.

$9,660in general payments, 2019–2025

Across 56 payments — averaging $172.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • THD America, Inc.$890
  • Medtronic$286
  • Musculoskeletal Transplant Foundation Inc.$283
  • Davol Inc.$237
  • Olympus America Inc.$209
  • plus $578 from 6 others
$105,895in research payments, 2019–2025

Across 56 payments — averaging $1890.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biontech SE$58K
  • GSK$48K

What the payments were for

  • Travel & lodging$2,98531%
  • Food & beverage$3,10932%
  • Education$3,56737%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few colon & rectal surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$129,141
Medicare patients
240
Services billed
587

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate60$271
Metronidazole59$129

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Westwood

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →